Strangvac, a vaccine against equine strangles released for sales in Italy
Stockholm, December 13th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac, a vaccine against the highly contagious bacterial equine disease Strangles, has been released for sale in Italy. Dechra Pharmaceuticals PLC distributes the vaccine in Italy and in a number of other European countries. “The first batch of Strangvac for Italy has now been released. This means that sales of Strangvac in Italy can begin”, explains Andreas Johansson, Logistics Manager at Intervacc. “Streptococcus equi causes significant suffering in populations of horses in Italy. I have